IpsiHand® is an FDA-cleared, non-invasive treatment of stroke. See if you qualify →

  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
  • How It Works
  • Get IpsiHand
  • Resources
  • For Clinicians
Do I Qualify?
Unlocking Language with Melodic Intonation Therapy: A Pathway to Speech Recovery in Stroke Survivors

Unlocking Language with Melodic Intonation Therapy: A Pathway to Speech Recovery in Stroke Survivors

by CicadaDev | Feb 18, 2026 | After Stroke, Medical Education, Treatment

The following guide explains how Melodic Intonation Therapy works, who it helps most after stroke or Traumatic Brain Injury (TBI), and how speech therapists use it alongside other treatments to support speech recovery. What is Melodic Intonation Therapy? Melodic...

Recent Posts

  • Unlocking Language with Melodic Intonation Therapy: A Pathway to Speech Recovery in Stroke Survivors
  • Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation
  • Dr. Eric Leuthardt to Present Randomized Controlled Trial results on IpsiHand® at International Stroke Conference 2026
  • Cognitive Rehabilitation Exercises for Memory and Attention After Stroke
  • Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

Recent Comments

No comments to show.
About IpsiHand
  • How It Works
  • Get IpsiHand
  • Testimonials
  • Orthoses vs Therapeutic Devices
Resources
  • Resource Library
  • Insurance Coverage
  • Veterans Benefits
  • IpsiHand FAQ
    • FAQ Healthcare Professionals
  • Stroke Insights and Answers
  • News & Articles
  • For Clinicians
Company
  • About Neurolutions
  • Team
  • Careers
  • Contact Us
  • Important Safety Information
  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy

.

  • Notice of Non-Discrimination
  • Notice of Privacy Practices
  • Privacy Policy
  • FCOI Policy
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
neurolutions logo
© Neurolutions, Inc. 2026. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Leo Petrossian

Leo Petrossian

Leo Petrossian is the current Chief Executive Officer of Neurolutions, Inc. He is an experienced nanotechnologist searching for challenging opportunities in biotechnology and medical device entre- and intrapreneurship. Previously he co-founded Neural Analytics and is also the CEO of Nile AI, Inc.

Dr. Petrossian earned his MBA from the UCLA Anderson School of Management in 2014 and earned his Ph.D. & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.